1. Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications

   • Evangelos Terpos
   • Meletios A. Dimopoulos

   Review 18 January 2011 Pages: 305 - 317

   

2. 2011: the immune hallmarks of cancer

   • Federica Cavallo
   • Carla De Giovanni
   • Pier-Luigi Lollini

   Symposium-In-Writing Open access 26 January 2011 Pages: 319 - 326

3. A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination

   • Anne Rogel
   • Virginie Vignard
   • François Lang

   Original Article 16 November 2010 Pages: 327 - 337

   

4. In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models

   • Guodong Shen
   • Hui Huang
   • Wei Wei

   Original Article 18 November 2010 Pages: 339 - 348

   

5. Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens

   • Huanfa Yi
   • Xiaofei Yu
   • Xiang-Yang Wang

   Original Article 19 November 2010 Pages: 349 - 360

   

6. Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro

   • Haishan Li
   • C. David Pauza

   Original Article 25 November 2010 Pages: 361 - 370

   

7. Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer

   • Elisabeth Roider
   • Stefan Jellbauer
   • Klaus Panthel

   Original Article 04 December 2010 Pages: 371 - 380

   

8. Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production

   • Adele Y. Wang
   • Sarah Q. Crome
   • Megan K. Levings

   Original Article 14 December 2010 Pages: 381 - 388

   

9. Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma

   • Andrea Maglioco
   • Damián Machuca
   • Graciela I. Dran

   Original Article 14 December 2010 Pages: 389 - 399

   

10. Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients

    • Christoph Domschke
    • Florian Schuetz
    • Philipp Beckhove

    Original article 14 December 2010 Pages: 401 - 411

    

11. Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges

    • Madhav V. Dhodapkar
    • Kavita M. Dhodapkar

    Focussed Research Review 23 November 2010 Pages: 413 - 418

12. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer

    • Rupal Ramakrishnan
    • Dmitry I. Gabrilovich

    Focussed Research Review 26 October 2010 Pages: 419 - 423

    

13. Suppression of T-cell responses by tumor metabolites

    • Katrin Singer
    • Eva Gottfried
    • Andreas Mackensen

    Focussed Research Review 15 January 2011 Pages: 425 - 431

    

14. Immunologic biomarkers as correlates of clinical response to cancer immunotherapy

    • Mary L. Disis

    Focussed Research Review 08 January 2011 Pages: 433 - 442

    

15. CIMT 2010: Report on the eighth annual meeting of the association for cancer immunotherapy, May 26–28, 2010, Mainz, Germany

    • Satwinder Kaur Singh
    • Karoline Laske
    • Marij J. P. Welters

    Meeting Report 23 November 2010 Pages: 443 - 450

16. Acknowledgement

    Acknowledgement to reviewers 09 February 2011 Pages: 451 - 455